Cerebrospinal fluid cytokines after autologous haematopoietic stem cell transplantation and intrathecal rituximab treatment for multiple sclerosis
Joachim Burman(Uppsala University), Kim Kultima(Uppsala University), Christina Zjukovskaja(Uppsala University Hospital), Anders Svenningsson(Karolinska Institutet), Anna Wiberg(Uppsala University), Eva Freyhult(Science for Life Laboratory)
Cited by 9
Related Papers
Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab
|Annals of Neurology|2010|347
Faced with inequality: chicken do not have a general dosage compensation of sex-linked genes
|BMC Biology|2007|257
Neurofilament and glial fibrillary acidic protein in multiple sclerosis
|Neurology|2004|245
Treatment Escalation vs Immediate Initiation of Highly Effective Treatment for Patients With Relapsing-Remitting Multiple Sclerosis
|JAMA Neurology|2021|237
PhenoMeNal: processing and analysis of metabolomics data in the cloud
|GigaScience|2018|147